nivolumab,tegafur,oxaliplatin,oteracil,gimeracil,capecitabine
ono pharma,nordic group,otsuka,bms
['nivo', 'gastric', 'nivolumab', 'esophageal', 'attraction-5', 'gastroesophageal', 'crown']
don't miss this talk today at #asco23! attraction-5: a phase 3 study of #nivolumab + #chemotherapy as postoperative adjuvant treatment for pathological stage iii gastric or gastroesophageal junction (g/gej) cancer 14:45 gmt-5, arie crown theater 
COR2ED bringing you Independent Medical Education developed 
by GI CONNECT, international experts in GI oncology